Neutropenia pathophysiology
Jump to navigation
Jump to search
Neutropenia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Neutropenia pathophysiology On the Web |
American Roentgen Ray Society Images of Neutropenia pathophysiology |
Risk calculators and risk factors for Neutropenia pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Daniel A. Gerber, M.D. [2]
Overview
Neutropenia may develop as a result of one of the three mechanisms: impaired granulocyte production, margination, and peripheral destruction. Genes involved in the pathogenesis of neutropenia include ELA2, HAX1, and CXCR4.
Pathophysiology
Pathogenesis
Neutropenia may develop as a result of one of the three mechanisms:[1]
- Impaired granulocyte production
- Hematologic malignancy with bone marrow infiltration
- Myelosuppressive chemotherapy or other medications that are toxic to the bone marrow
- Nutritional deficiencies
- Margination (process where free flowing blood cells exit circulation)
- Splenic sequestration
- Adherence to the vascular endothelium
- Peripheral destruction
- Autoimmune hemolysis
- Drug-induced hemolysis
Genetics
Genes involved in the pathogenesis of neutropenia include ELA2, HAX1, and CXCR4.
References
- ↑ Schwartzberg LS. (2006). "Neutropenia: etiology and pathogenesis". Clin Cornerstone. 8 (5): 5–11. Text "pmid 17379162" ignored (help)